CNS

GH001 (Inhaled 5-MeO-DMT)

GH Research

Inhaled 5-MeO-DMT. INVOKE-2 Phase 2b positive. Ultra-short duration (~30 min). Phase 3 KANNA program initiated. Otsuka strategic interest.

Treatment-Resistant Depression

Linked Studies

A PMCF Study to Confirm the Performance and Safety of the LeMaitre® TufTex Single Lumen Embolectomy Catheter

Loading comments…

Also Known As

Development codes

GH001

Other names

gh001